Optimizing Caffeine Use and Risk of Bronchopulmonary Dysplasia in Preterm Infants

A Systematic Review, Meta-analysis, and Application of Grading of Recommendations Assessment, Development, and Evaluation Methodology
Published:March 07, 2018DOI:https://doi.org/10.1016/j.clp.2018.01.012

      Keywords

      To read this article in full you will need to make a payment
      Purchase one-time access
      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.
      Content published before 2002 is available via pay-per-view purchase only.
      Subscribe to Clinics in Perinatology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Aranda J.V.
        • Gorman W.
        • Bergsteinsson H.
        • et al.
        Efficacy of caffeine in treatment of apnea in the low-birth-weight infant.
        J Pediatr. 1977; 90: 467-472
        • Kuzemko J.A.
        • Paala J.
        Apnoeic attacks in the newborn treated with aminophylline.
        Arch Dis Child. 1973; 48: 404-406
        • Hsieh E.M.
        • Hornik C.P.
        • Clark R.H.
        • et al.
        Medication use in the neonatal intensive care unit.
        Am J Perinatol. 2014; 31: 811-821
        • Krzyzaniak N.
        • Pawlowska I.
        • Bajorek B.
        Review of drug utilization patterns in NICUs worldwide.
        J Clin Pharm Ther. 2016; 41: 612-620
        • Schmidt B.
        • Roberts R.S.
        • Davis P.
        • et al.
        Caffeine therapy for apnea of prematurity.
        N Engl J Med. 2006; 354: 2112-2121
        • Schmidt B.
        • Roberts R.S.
        • Davis P.
        • et al.
        Long-term effects of caffeine therapy for apnea of prematurity.
        N Engl J Med. 2007; 357: 1893-1902
        • Schmidt B.
        • Roberts R.S.
        • Anderson P.J.
        • et al.
        Academic performance, motor function, and behavior 11 years after neonatal caffeine citrate therapy for apnea of prematurity: an 11-year follow-up of the CAP randomized clinical trial.
        JAMA Pediatr. 2017; 171: 564-572
        • Davis P.G.
        • Schmidt B.
        • Roberts R.S.
        • et al.
        Caffeine for apnea of prematurity trial: benefits may vary in subgroups.
        J Pediatr. 2010; 156: 382-387
        • Lodha A.
        • Seshia M.
        • McMillan D.D.
        • et al.
        Association of early caffeine administration and neonatal outcomes in very preterm neonates.
        JAMA Pediatr. 2015; 169: 33-38
        • Gupte A.S.
        • Gupta D.
        • Ravichandran S.
        • et al.
        Effect of early caffeine on neurodevelopmental outcome of very low-birth weight newborns.
        J Matern Fetal Neonatal Med. 2016; 29: 1233-1237
        • Katheria A.C.
        • Sauberan J.B.
        • Akotia D.
        • et al.
        A pilot randomized controlled trial of early versus routine caffeine in extremely premature infants.
        Am J Perinatol. 2015; 32: 879-886
        • Steer P.
        • Flenady V.
        • Shearman A.
        • et al.
        High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial.
        Arch Dis Child Fetal Neonatal Ed. 2004; 89: F499-F503
        • McPherson C.
        • Neil J.J.
        • Tjoeng T.H.
        • et al.
        A pilot randomized trial of high-dose caffeine therapy in preterm infants.
        Pediatr Res. 2015; 78: 198-204
        • Abu Jawdeh E.G.
        • O'Riordan M.
        • Limrungsikul A.
        • et al.
        Methylxanthine use for apnea of prematurity among an international cohort of neonatologists.
        J Neonatal Perinatal Med. 2013; 6: 251-256
        • Eichenwald E.C.
        • Blackwell M.
        • Lloyd J.S.
        • et al.
        Inter-neonatal intensive care unit variation in discharge timing: influence of apnea and feeding management.
        Pediatrics. 2001; 108: 928-933
        • Moher D.
        • Liberati A.
        • Tetzlaff J.
        • et al.
        Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.
        BMJ. 2009; 339: b2535
        • Guyatt G.H.
        • Oxman A.D.
        • Vist G.E.
        • et al.
        GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.
        BMJ. 2008; 336: 924-926
        • Schunemann H.J.
        • Jaeschke R.
        • Cook D.J.
        • et al.
        An official ATS statement: grading the quality of evidence and strength of recommendations in ATS guidelines and recommendations.
        Am J Respir Crit Care Med. 2006; 174: 605-614
        • Kua K.P.
        • Lee S.W.
        Systematic review and meta-analysis of clinical outcomes of early caffeine therapy in preterm neonates.
        Br J Clin Pharmacol. 2017; 83: 180-191
        • Park H.W.
        • Lim G.
        • Chung S.H.
        • et al.
        Early caffeine use in very low birth weight infants and neonatal outcomes: a systematic review and meta-analysis.
        J Korean Med Sci. 2015; 30: 1828-1835
        • Dobson N.R.
        • Patel R.M.
        • Smith P.B.
        • et al.
        Trends in caffeine use and association between clinical outcomes and timing of therapy in very low birth weight infants.
        J Pediatr. 2014; 164: 992-998.e3
        • Patel R.M.
        • Leong T.
        • Carlton D.P.
        • et al.
        Early caffeine therapy and clinical outcomes in extremely preterm infants.
        J Perinatol. 2013; 33: 134-140
        • Taha D.
        • Kirkby S.
        • Nawab U.
        • et al.
        Early caffeine therapy for prevention of bronchopulmonary dysplasia in preterm infants.
        J Matern Fetal Neonatal Med. 2014; 27: 1698-1702
        • Hand I.
        • Zaghloul N.
        • Barash L.
        • et al.
        Timing of caffeine therapy and neonatal outcomes in preterm infants: a retrospective study.
        Int J Pediatr. 2016; 2016: 9478204
        • Dekker J.
        • Hooper S.B.
        • van Vonderen J.J.
        • et al.
        Caffeine to improve breathing effort of preterm infants at birth: a randomized controlled trial.
        Pediatr Res. 2017; 82: 290-296
        • Gray P.H.
        • Flenady V.J.
        • Charles B.G.
        • et al.
        Caffeine Collaborative Study Group. Caffeine citrate for very preterm infants: Effects on development, temperament and behaviour.
        J Paediatr Child Health. 2011; 47: 167-172
        • Mohammed S.
        • Nour I.
        • Shabaan A.E.
        • et al.
        High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial.
        Eur J Pediatr. 2015; 174: 949-956
        • Steer P.A.
        • Flenady V.J.
        • Shearman A.
        • et al.
        Periextubation caffeine in preterm neonates: a randomized dose response trial.
        J Paediatr Child Health. 2003; 39: 511-515
        • Romagnoli C.
        • De Carolis M.P.
        • Muzii U.
        • et al.
        Effectiveness and side effects of two different doses of caffeine in preventing apnea in premature infants.
        Ther Drug Monit. 1992; 14: 14-19
        • Vesoulis Z.A.
        • McPherson C.
        • Neil J.J.
        • et al.
        Early high-dose caffeine increases seizure burden in extremely preterm neonates: a preliminary study.
        J Caffeine Res. 2016; 6: 101-107
        • Hussein M.A.
        • Coats D.K.
        • Khan H.
        • et al.
        Evaluating the association of autonomic drug use to the development and severity of retinopathy of prematurity.
        J AAPOS. 2014; 18: 332-337
        • Rhein L.M.
        • Dobson N.R.
        • Darnall R.A.
        • et al.
        Effects of caffeine on intermittent hypoxia in infants born prematurely: a randomized clinical trial.
        JAMA Pediatr. 2014; 168: 250-257
        • Tabacaru C.R.
        • Jang S.Y.
        • Patel M.
        • et al.
        Impact of caffeine boluses and caffeine discontinuation on apnea and hypoxemia in preterm infants.
        J Caffeine Res. 2017; 7: 103-110
        • Sweet D.G.
        • Carnielli V.
        • Greisen G.
        • et al.
        European consensus guidelines on the management of respiratory distress syndrome - 2016 update.
        Neonatology. 2017; 111: 107-125
        • Eichenwald E.C.
        • American Academy of Pediatrics Committee on Fetus and Newborn
        Apnea of prematurity.
        Pediatrics. 2016; 137